题名 | H2S Donor and Bone Metabolism |
作者 | |
通讯作者 | Gao, Yan; Li, Chong |
发表日期 | 2021-07-22
|
DOI | |
发表期刊 | |
EISSN | 1663-9812
|
卷号 | 12 |
摘要 | Hydrogen sulfide (H2S) has been recognized as the third gasotransmitter, following nitric oxide and carbon monoxide, and it exerts important biological effects in the body. Growing evidence has shown that H2S is involved in many physiological processes in the body. In recent years, much research has been carried out on the role of H2S in bone metabolism. Bone metabolic diseases have been linked to abnormal endogenous H2S functions and metabolism. It has been found that H2S plays an important role in the regulation of bone diseases such as osteoporosis and osteoarthritis. Regulation of H2S on bone metabolism has many interacting signaling pathways at the molecular level, which play an important role in bone formation and absorption. H2S releasing agents (donors) have achieved significant effects in the treatment of metabolic bone diseases such as osteoporosis and osteoarthritis. In addition, H2S donors and related drugs have been widely used as research tools in basic biomedical research and may be explored as potential therapeutic agents in the future. Donors are used to study the mechanism and function of H2S as they release H2S through different mechanisms. Although H2S releasers have biological activity, their function can be inconsistent. Additionally, donors have different H2S release capabilities, which could lead to different effects. Side effects may form with the formation of H2S; however, it is unclear whether these side effects affect the biological effects of H2S. Therefore, it is necessary to study H2S donors in detail. In this review, we summarize the current information about H2S donors related to bone metabolism diseases and discuss some mechanisms and biological applications. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 其他
|
资助项目 | Suzhou Science and Technology Plan Project[230301,"SYS2020061"]
|
WOS研究方向 | Pharmacology & Pharmacy
|
WOS类目 | Pharmacology & Pharmacy
|
WOS记录号 | WOS:000681060200001
|
出版者 | |
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:21
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/242698 |
专题 | 南方科技大学医学院_药理学系 |
作者单位 | 1.Peoples Hosp Kunshan 1, Dept Orthoped, Kunshan, Peoples R China 2.Peoples Hosp Kunshan 1, Dept Endocrinol, Kunshan, Peoples R China 3.Southern Univ Sci & Technol, Dept Pharmacol, Shenzhen, Peoples R China |
推荐引用方式 GB/T 7714 |
Hao, Yanming,Wang, Hongzhen,Fang, Lingna,et al. H2S Donor and Bone Metabolism[J]. FRONTIERS IN PHARMACOLOGY,2021,12.
|
APA |
Hao, Yanming,Wang, Hongzhen,Fang, Lingna,Bian, Jinsong,Gao, Yan,&Li, Chong.(2021).H2S Donor and Bone Metabolism.FRONTIERS IN PHARMACOLOGY,12.
|
MLA |
Hao, Yanming,et al."H2S Donor and Bone Metabolism".FRONTIERS IN PHARMACOLOGY 12(2021).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论